Swiss biotech business Symetis raises €15m in venture funding | AltAssets Private Equity News

Subscribe today

Advanced
Search

Swiss biotech business Symetis raises €15m in venture funding

2 Jul 2009

Lausanne-based biotechnology company Symetis has raised CHF23m (€15.1m) in a financing round co-led by Wellington Partners and Vinci Capital–Renaissance.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.